Methylmalonic aciduria cblB type: characterization of two novel mutations and mitochondrial dysfunction studies

Autor: Brasil, S, Richard, E, Jorge-Finnigan, A, Leal, F, Merinero, B, Banerjee, R, Desviat, L R, Ugarte, M, Pérez, B
Přispěvatelé: Ministerio de Economía y Competitividad (España), Ministerio de Sanidad, Servicios Sociales e Igualdad (España), Fundação para a Ciência e a Tecnologia (Portugal), Fundación Ramón Areces
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Popis: © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Methylmalonic aciduria (MMA) cblB type is caused by mutations in the MMAB gene, which codes for the enzyme adenosine triphosphate (ATP): cobalamin adenosyltransferase (ATR). This study reports differences in the metabolic and disease outcomes of two pairs of siblings with MMA cblB type, respectively harbouring the novel changes p.His183Leu/p.Arg190dup (P1 and P2) and the previously described mutations p.Ile96Thr/p.Ser174fs (P3 and P4). Expression analysis showed p.His183Leu and p.Arg190dup to be destabilizing mutations. Both were associated with reduced ATR stability and a shorter half-life than wild-type ATR. Analysis of several parameters related to oxidative stress and mitochondrial function showed an increase in reactive oxygen species (ROS) content, a decrease in mitochondrial respiration and changes in mitochondria morphology and structure in patient-derived fibroblasts compared to control cells. The impairment in energy production and the presence of oxidative stress and fission of the mitochondrial reticulum suggested mitochondrial dysfunction in cblB patients' fibroblasts. The recovery of mitochondrial function should be a goal in efforts to improve the clinical outcome of MMA cblB type.
Ministerio de Economía y Competividad (SAF2010-15284 to E. R.) and the National Institutes of Health (DK45776 to R. B.). S. B. was supported by a grant from the Fundação para a Ciência e Tecnologia of Portugal (SFRH/BD/45753/2008). An institutional grant from the Fundación Ramón Areces to the Centro de Biología Molecular Severo Ochoa is gratefully acknowledged.
Databáze: OpenAIRE